Although no significant differences were observed in the incidence of MAEs, the RAPID-CHD Pathway showed a trend toward reduced MAEs (aOR, 0.36; 95% CI, 0.11 ~ 1.20).
← all excerpts
RAPID-CHD pathway improves clinical outcomes in neonates with congenital heart disease.
1
—
—